Filing Details

Accession Number:
0001127602-13-017713
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-21 17:11:26
Reporting Period:
2013-05-17
Filing Date:
2013-05-21
Accepted Time:
2013-05-21 17:11:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1520262 Alkermes Plc. ALKS Pharmaceutical Preparations (2834) 981007018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1376548 Elliot Ehrich 852 Winter St.
Waltham MA 02451
Svp, R&D & Cmo, Alkermes, Inc. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2013-05-17 4,175 $0.00 20,754 No 4 M Direct
Ordinary Shares Disposition 2013-05-17 1,971 $31.69 18,783 No 4 F Direct
Ordinary Shares Disposition 2013-05-20 2,204 $31.59 16,579 No 4 S Direct
Ordinary Shares Acquisiton 2013-05-20 3,750 $0.00 20,329 No 4 M Direct
Ordinary Shares Disposition 2013-05-20 1,770 $31.04 18,559 No 4 F Direct
Ordinary Shares Disposition 2013-05-21 1,980 $30.56 16,579 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Restricted Stock Unit Award Disposition 2013-05-17 4,175 $0.00 4,175 $0.00
Ordinary Shares Restricted Stock Unit Award Disposition 2013-05-20 3,750 $0.00 3,750 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,175 2011-05-17 No 4 M Direct
7,500 2012-05-20 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 5/17/11.
  3. Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 5/20/12.